Braves Extend Chris Sale Through 2027 Season

Well, Chris Sale no longer has to do what he does under the cloud of a one-year contract. On Tuesday, the Braves announced they’d signed their soon-to-be 37-year-old ace to a one-year contract extension with a team option for 2028. The deal represents a huge raise. Sale is making $18 million this year – the team option year at the end of the two-year extension he signed back in 2024 – and the new extension will pay him $27 million in 2027. If the Braves pick up the 2028 option, they’ll pay him $30 million. No word of a buyout for that final year has been reported, and the announcement included no mention of a 1% donation to the Atlanta Braves Foundation.
Even though the Braves are not getting the kind of discount you associate with a contract extension, this seems like a no-brainer for them. Yes, they’re paying ace prices for the age-37 (and possibly age-38) season of a pitcher whose injury history includes a Tommy John surgery and five variations on the word “fracture.” But Sale really is an ace, and his performance has showed no signs of dropping off. Since he arrived in Atlanta in 2024 (and for the sake of Red Sox fans, I won’t mention how he got there), Sale has a 25-8 record with a 2.46 ERA and 2.33 FIP. He’s struck out nearly a third of the batters he’s faced, and he won the Cy Young award in his first season with the team. In 2025, his four-seamer averaged 94.8 mph. That’s above average, especially for a left-handed starter, and especially for someone with a funky sidearm delivery, and especially when you factor in the bump in effective velocity due to the above-average extension from his 6-foot-6 frame. That’s a lot of especiallys making Sale’s velocity play up, and it’s reassuring to know that it has looked pretty stable in recent years.







